These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 30616644)

  • 1. Elevated plasma level of soluble triggering receptor expressed on myeloid cells-1 is associated with inflammation activity and is a potential biomarker of thrombosis in primary antiphospholipid syndrome.
    Edel Y; Kliminski V; Pokroy-Shapira E; Oren S; Dortort Lazar A; Pri-Paz Basson Y; Egbaria M; Molad Y
    Arthritis Res Ther; 2019 Jan; 21(1):10. PubMed ID: 30616644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Plasma Soluble Triggering Receptor Expressed on Myeloid Cells-1 Level in Patients with Acute Coronary Syndrome (ACS): A Biomarker of Disease Severity and Outcome.
    Shiber S; Kliminski V; Orvin K; Sagy I; Vaturi M; Kornowski R; Drescher M; Molad Y
    Mediators Inflamm; 2021; 2021():8872686. PubMed ID: 33814983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory markers in thrombosis associated with primary antiphospholipid syndrome.
    Arantes FT; Mazetto BM; Saraiva SS; Tobaldini LQ; Dos Santos APR; Annichino-Bizzacchi J; Orsi FA
    J Thromb Thrombolysis; 2020 Nov; 50(4):772-781. PubMed ID: 32462539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19.
    de Nooijer AH; Grondman I; Lambden S; Kooistra EJ; Janssen NAF; Kox M; Pickkers P; Joosten LAB; van de Veerdonk FL; Derive M; Gibot S; Netea MG;
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34195785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Serum sTREM-1 as a Marker of Subclinical Inflammation in Diarrhea-Predominant Patients with Irritable Bowel Syndrome.
    Du C; Peng L; Kou G; Wang P; Lu L; Li Y
    Dig Dis Sci; 2018 May; 63(5):1182-1191. PubMed ID: 29516326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum sTREM-1 in adult-onset Still's disease: a novel biomarker of disease activity and a potential predictor of the chronic course.
    Wang Z; Chi H; Sun Y; Teng J; Feng T; Liu H; Cheng X; Ye J; Shi H; Hu Q; Jia J; Liu T; Wan L; Zhou Z; Qiao X; Yang C; Su Y
    Rheumatology (Oxford); 2020 Nov; 59(11):3293-3302. PubMed ID: 32276274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble triggering receptor expressed on myeloid cells-1 as a serum biomarker of early neurologic deterioration and prognosis in acute supratentorial intracerebral hemorrhage.
    Gu Y; Deng X; Liang C; Chen Y; Lei H; Zhang Q
    Clin Chim Acta; 2021 Dec; 523():290-296. PubMed ID: 34655609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipocytokines in primary antiphospholipid syndrome: potential markers of low-grade inflammation, insulin resistance and metabolic syndrome.
    Rodrigues CE; Vendramini MB; Bueno C; Bonfá E; de Carvalho JF
    Clin Exp Rheumatol; 2012; 30(6):871-8. PubMed ID: 22935544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison the Serum STREM1 Levels Between Children with Upper and Lower UTI.
    Ehsanipour F; Noorbakhsh S; Zarabi V; Movahedi Z; Rahimzadeh N
    Curr Pediatr Rev; 2017; 13(2):152-156. PubMed ID: 28215176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical performance of antibodies to prothrombin and thrombin in Chinese patients with antiphospholipid syndrome: potential interest in discriminating patients with thrombotic events and non-thrombotic events.
    Zhang S; Wu Z; Li J; Li P; Chen S; Wen X; Li L; Zhang W; Zhao J; Zhang F; Li Y
    Rheumatol Int; 2017 Apr; 37(4):579-584. PubMed ID: 27807637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of triggering receptors expressed by myeloid cells-1 in macrophages stimulated by Porphyromonas gingivalis-lipopolysaccharide].
    Yang Y; Chen SS; Xu CM; Wu YF; Zhao L
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2018 Oct; 36(5):475-481. PubMed ID: 30465338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic risk factors in primary antiphospholipid syndrome: a 5-year prospective study.
    Turiel M; Sarzi-Puttini P; Peretti R; Rossi E; Atzeni F; Parsons W; Doria A
    Stroke; 2005 Jul; 36(7):1490-4. PubMed ID: 15947270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-grade endotoxemia and risk of recurrent thrombosis in primary antiphospholipid syndrome. The multicenter ATHERO-APS study.
    Bucci T; Ames PRJ; Cammisotto V; Cardamone C; Ciampa A; Mangoni B; Triggiani M; Carnevale R; Lip GYH; Pastori D; Pignatelli P;
    Thromb Res; 2023 Nov; 231():76-83. PubMed ID: 37827070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma microparticle tissue factor activity in patients with antiphospholipid antibodies with and without clinical complications.
    Willemze R; Bradford RL; Mooberry MJ; Roubey RA; Key NS
    Thromb Res; 2014 Feb; 133(2):187-9. PubMed ID: 24332063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between plasmatic oxidative stress and thrombosis in primary antiphospholipid syndrome.
    Vaz CO; Mazetto BM; Vasconcelos PENS; Bastos LB; Cursino MA; Quintanilha JCF; Mesquita GLTV; Santos APR; Jacintho BC; Oliveira JD; Annichino-Bizzachi J; Orsi FA
    J Thromb Thrombolysis; 2021 Oct; 52(3):730-737. PubMed ID: 34224066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome.
    Kopytek M; Natorska J; Undas A
    Lupus; 2018 Apr; 27(5):812-819. PubMed ID: 29338587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome.
    Patsouras MD; Sikara MP; Grika EP; Moutsopoulos HM; Tzioufas AG; Vlachoyiannopoulos PG
    J Autoimmun; 2015 Dec; 65():30-7. PubMed ID: 26283469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABO blood group in primary antiphospholipid syndrome: influence in the site of thrombosis?
    Nascimento NM; Bydlowski SP; Soares RP; de Andrade DC; Bonfá E; Seguro LP; Borba EF
    J Thromb Thrombolysis; 2015 Oct; 40(3):374-8. PubMed ID: 25638331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of antibody profile in thrombosis associated with primary antiphospholipid syndrome.
    da Silva Saraiva S; de Moraes Mazetto B; Quinteiro Tobaldine L; Pereira Colella M; Vinícius De Paula E; Annichinno-Bizzachi J; Andrade Orsi F
    Am J Hematol; 2017 Nov; 92(11):1163-1169. PubMed ID: 28762539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polymorphism of the plasminogen activator inhibitor type 1 gene, plasminogen level and thrombosis in patients with antiphospholipid syndrome].
    Aĭsina RB; Mukhametova LI; Ostriakova EV; Seredavkina NV; Patrushev LI; Patrusheva NL; Reshetniak TM; Gulin DA; Gershkovich KB; Nasonov EL; Varfolomeev SD
    Biomed Khim; 2014; 60(1):72-93. PubMed ID: 24749249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.